Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
0.7061
+0.0051 (0.73%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Accelerate Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
18305770364432
Upgrade
Market Cap Growth
-47.31%-47.31%-18.48%-80.76%-15.88%-53.19%
Upgrade
Enterprise Value
68687291420502
Upgrade
Last Close Price
0.701.203.927.0652.2075.80
Upgrade
PS Ratio
1.402.574.735.4930.8738.72
Upgrade
PB Ratio
-0.32-0.54-2.87-3.14-10.37-6.88
Upgrade
EV/Sales Ratio
5.825.826.017.1735.6844.99
Upgrade
Debt / Equity Ratio
-1.19-1.19-1.97-3.48-3.17-2.39
Upgrade
Asset Turnover
0.390.390.250.170.130.10
Upgrade
Inventory Turnover
2.922.922.241.841.700.78
Upgrade
Quick Ratio
0.590.591.320.729.4910.02
Upgrade
Current Ratio
0.710.712.030.8410.5611.77
Upgrade
Return on Assets (ROA)
-73.66%-73.66%-70.07%-53.02%-50.69%-34.73%
Upgrade
Return on Capital (ROIC)
-147.77%-147.77%-90.52%-59.78%-54.81%-37.00%
Upgrade
Earnings Yield
-281.64%-166.52%-108.03%-89.32%-21.37%-18.09%
Upgrade
FCF Yield
-139.02%-82.20%-72.29%-70.44%-13.18%-11.97%
Upgrade
Buyback Yield / Dilution
-86.76%-86.76%-51.86%-33.10%-10.21%-2.76%
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q